Another day, another product recall in SA: This time it’s Citro-Soda
· The South African
Health authorities have issued a targeted recall of specific batches of Citro-Soda after a contamination risk was identified, adding to a string of recent safety alerts affecting everyday South African products.
Consumers are being urged to check their medicine cabinets after a recall of specific batches of Citro-Soda Regular.
Visit salonsustainability.club for more information.
South Africa has seen a steady stream of product recalls of late. It has spanned everything from food to medicines to popular vehicles.
Earlier this year, certain baby formula products were pulled from shelves over safety concerns, while a major recall of dry pet food was issued due to possible salmonella contamination.
The National Consumer Commission has also flagged food items like peanut butter for elevated toxin levels.
The South African Health Products Regulatory Authority (SAHPRA), together with Adcock Ingram, has issued the Citro-Soda recall following the discovery of potential foreign material contamination at the company’s Clayville manufacturing facility in Johannesburg .
The recall applies only to certain batches of:
- Citro-Soda Regular 60g
- Citro-Soda Regular 120g
- Citro-Soda Regular 4g x 30 sachets
What consumers need to know about the recall
According to the official recall notice, the affected products are limited to batches manufactured at the Clayville plant and expiring on or before November 2027 .
These batches can be identified by their batch numbers, which begin with the letter “C”.
Importantly, SAHPRA confirmed that Citro-Soda products made at other Adcock Ingram facilities are not affected, and neither is the Citro-Soda Cranberry variant .
What is Citro-Soda used for?
Citro-Soda is an over-the-counter antacid powder used to relieve indigestion, heartburn and upset stomach.
It is also used to help relieve symptoms of bladder infections by reducing urine acidity, which can ease burning.
Media briefing to unpack the recall
The recall has been classified as a Class II, Type A recall. This means the products may cause “temporary or medically reversible adverse health problems.”
Consumers are advised to stop using the affected products and return them to the place of purchase for a refund/ replacement.
SAHPRA is expected to provide further clarity during a media briefing in Pretoria next week.
The session will outline the reasons behind the recall, the regulatory response, and guidance for healthcare professionals and the public.
Retailers, wholesalers and healthcare providers have also been instructed to remove affected stock from circulation immediately.
Consumers are encouraged to verify batch numbers and follow official guidance as more information becomes available.